Golumbeski George

Acumen Pharmaceuticals, Inc. · Director

Golumbeski George is listed in public filings as director. This Golumbeski George insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Acumen Pharmaceuticals, Inc. (ABOS), Shattuck Labs, Inc. (STTK), and Sage Therapeutics, Inc. (SAGE). Investors use Golumbeski George's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Acumen Pharmaceuticals, Inc.ABOS--35.5k sharesGrant / ExerciseJun 3, 2026Disclosure amount unavailable35.5k shares----
Acumen Pharmaceuticals, Inc.ABOS$122k53.3k sharesGrant / ExerciseJun 3, 2026$121.9K53.3k shares$2.29--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Shattuck Labs, Inc.STTK$482k81k sharesGrant / ExerciseMay 29, 2026$481.9K81k shares$5.95--
Acumen Pharmaceuticals, Inc.ABOS$95k50k sharesGrant / ExerciseNov 6, 2025$95.0K50k shares$1.90--
Sage Therapeutics, Inc.SAGE$021.5k sharesOtherJul 31, 2025$145.6K21.5k shares$6.77--
Sage Therapeutics, Inc.SAGE$013.6k sharesOtherJul 31, 2025$83.5K13.6k shares$6.14--
Sage Therapeutics, Inc.SAGE$08k sharesOtherJul 31, 2025$28.0K8k shares$3.50--
Shattuck Labs, Inc.STTK$27k33.2k sharesGrant / ExerciseJul 14, 2025$27.2K33.2k shares$0.82--
Sage Therapeutics, Inc.SAGE$146k21.5k sharesGrant / ExerciseJun 11, 2025$145.6K21.5k shares$6.77--
Sage Therapeutics, Inc.SAGE$83k13.6k sharesGrant / ExerciseJan 3, 2025$83.5K13.6k shares$6.14--
Shattuck Labs, Inc.STTK$121k27.7k sharesGrant / ExerciseJun 21, 2024$121.0K27.7k shares$4.37--
Sage Therapeutics, Inc.SAGE$136k12.5k sharesGrant / ExerciseJun 10, 2024$136.3K12.5k shares$10.90--